PanGIA Biotech to Expand Multi-Cancer Early Detection Liquid Biopsy Study
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Cancer, Research |
PanGIA Biotech is preparing to launch new clinical studies in multi-cancer early detection using the PanGIA Liquid Biopsy Platform.
Read MorePosted by Andy Lundin | Dec 13, 2023 | Lung Cancer |
DELFI Diagnostics is supporting the recently introduced Lung Cancer Screening and Prevention Act (H.R. 6693).
Read MorePosted by Andy Lundin | Nov 29, 2023 | Cancer, Molecular Diagnostics |
New research shows blood tests used to hunt for cancer DNA may help detect cancers faster and guide the use of targeted therapies
Read MorePosted by Chris Wolski | Nov 15, 2023 | Cancer |
Timely cancer detection paves the way for interventions that are less toxic, less disruptive, and less costly than treatment in later stages.
Read MorePosted by Andy Lundin | Nov 1, 2023 | Cancer |
Researchers developed a highly sensitive blood test that detects a key protein produced by cancer cells, showing promise for early detection.
Read More